公司資料
Kronos Bio 股價、新聞與催化劑
- 股票代碼:
- KRON
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for KRON.
公司概覽
業務概覽
Kronos Bio was an oncology company focused on epigenetic and transcriptional regulation in cancer before its restructuring and public-market decline. Its story centered on chromatin biology and targeted cancer therapy.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Kronos sat in oncology biotechnology.
商業模式特徵
The business depended on clinical data, target validation, and the ability to convert epigenetic science into therapeutic value.
生技產業定位
Kronos belongs to the historical oncology-biotech set rather than the current live public-company universe.
未來催化劑
- Kronos is now mostly a legacy / closeout story, so the catalysts are transaction or asset-resolution updates rather than fresh pipeline milestones. The market no longer treats it like an active growth name.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。